Your web browser is out of date! We recommend you update your browser to receive the best possible browsing experience.
Download your Brochure
Reserve your place

Conference Agenda

DAY 1: Tuesday 10th October 2017

7:30
-
8:45
REGISTRATION, EXHIBITION & WELCOME COFFEE
8:45
-
8:50
Opening Remarks from Organiser
8:50
-
9:30
Opening Panel discussion The new normal: Discover how the smartest companies are achieving access within a cash strapped economy
  • The future of the PBS, impact of the May budget and financial considerations on the healthcare industry
  • Do we only have two choices: to make better use of the money we have or to find more money?
  • The alternative to having more PBS funding
  • How to shape the business model of tomorrow to sustain the new normal

MSD Luke Cornish Senior Government Relations Manager MSD

Department of Health Penny Shakespeare First Assistant Secretary, Pharmaceutical Benefits Division Department of Health

9:30
-
10:00
Access in the Asian pharma market and what it means to Australia
  • The key players in the Asian pharma market – China, Taiwan, Korea and Hong Kong
  • The reimbursement reality and how it varies by market
  • The differences between access models and what Australia can learn from them

Alexion Pharmaceuticals Simon McErlane Regional Medical Director Alexion Pharmaceuticals

10:00
-
10:30
EXHIBITION & NETWORKING COFFEE BREAK
10:30
-
11:00
Primary Care Reform: the implications and opportunities for your company
  • Understand the drivers of change and model of care being targeted with these reforms
  • How the market will encourage innovation to shift the epicentre of care to the patient
  • Examine the impact of data collection and outcomes measurement on the patient management
  • Greater opportunities for the generation of real world data

Sonic Clinical Services Dr Munro Neville Chief Medical Officer Sonic Clinical Services

11:00
-
11:30
Fireside chat with Medicines Australia

Opportunity for you to have a conversation with Medicines Australia around policy, the Code of Conduct, general priorities, how they work with government and to understand how you are influencing the policy environment.

Medicines Australia Milton Catelin CEO and Government & Public Affairs Executive Medicines Australia

Medicines Australia Elizabeth de Somer Director Policy Medicines Australia

Medicines Australia Deborah Monk Director Ethics and Compliance Medicines Australia

Workshop
11:30
-
12:30
Atlantis Healthcare @ Boyd: Patient programs that get results – driving and measuring outcomes
  • Patient programs – the missed opportunity
  • Shaping patient behaviour, and measuring success
  • Real-world Evidence (RWE) – the Celgene experience

Speaker Logo

McCann Health @ Lindsay: Truth about Doctors
  • The rapidly changing world and role of doctors
  • Three global tensions that are impacting doctors world wide
  • The role pharma can play in helping doctors adapt, navigate, and thrive in these times of significant change

Speaker Logo

12:30
-
13:15
EXHIBITION & NETWORKING LUNCH BREAK & WORKSHOPS
13:15-13:45
Put the patient first. Uncovering pharma's value through the patient experience
  • What do patients really want and need?
  • Understanding the patient ecosystem including carers and loved ones
  • The key elements of a patient support program
  • How can pharma tangibly improve the patient experience?

Novartis Glenn Montgomery Director, Patient Access and Healthcare Systems Novartis

Novartis Simon Fisher Chief Scientific Officer Novartis

13:45
-
14:25
Panel discussion Create patient centric solutions. The increasing importance of patient advocacy organisations and the patient voice.
  • The critical nature of patient centricity for delivering value in the Australian Healthcare sector
  • The role of patient organisations in the current patient ecosystem
  • The elements of an ideal pharma-patient organisation relationship
  • Understand the support gaps and how can pharma step in to provide an improved patient centric experience

Novartis Glenn Montgomery Director, Patient Access and Healthcare Systems Novartis

Biogen Kylie Bromley Associate Director of Sales & Marketing Biogen

Epilepsy Action Australia Carol Ireland CEO & Managing Director Epilepsy Action Australia

MS Australia Deidre MacKechnie CEO MS Australia

14:25
-
14:55
Design & deploy a disease awareness campaign
  • The benefits of disease awareness campaigns and their roles in creating patient centric opportunities
  • The basic elements of an awareness campaign
  • Understand the negative effects of social stigma and the role of pharma in turning this around
  • Leveraging traditional media as well as digital channels
  • Working with key partners such as HCOs and/or media agencies

Galderma Jessica Danaher Brand Manager – ACNE and Rosacea Galderma

14:55
-
15:25
How to become the go-to source for healthcare content and increase engagement
  • The importance of credible content and reliable content sources for consumers and physicians
  • Why scientific data is the gateway to good engagement – and how you can use digital techniques to enhance communications
  • The benefits of enhanced content: how to measure ROI and plan for your success

Wiley Julia Ballard Senior Journal Publishing Manager Wiley

15:25
-
15:55
EXHIBITION & NETWORKING COFFEE BREAK
15:55
-
16:25
Inform your healthcare communications plan with updates on the latest trends and 2017 Pharma Marketing Automation Barometer results
  • Inspirational health & consumer marketing cases studies from around the globe.
  • Moving beyond traditional campaigns: machine learning, content, context and social techniques.
  • Highlights from a marketing technology readiness report on 14 of Australia’s largest pharma companies.
  • Current trends in the utilisation of marketing automation channels and functions.
  • Benchmarking HCP opt-in ratios: Are there any clear leaders in the pack?

Orchard

Speaker from Orchard to be confirmed

16:25
-
17:05
Panel discussion How to respond more effectively to our changing customers’ needs.
  • Understanding the pressures which are changing our customers’ behaviour
  • Recognise the pharma value-add and how to deliver it
  • Identify more innovative (and effective) means of communication
  • Altering our day to day activities need to better service our audience

iNova Pharma Roberto Castro Commercial Operations Manager iNova Pharma

AbbVie Alida Rossi Customer Excellence Director AbbVie


Further speakers to be revealed

17:05
-
19:00
EXHIBITION & NETWORKING DRINKS RECEPTION

DAY 2: Wednesday 11 October 2017

8:30
-
9:00
REGISTRATION, EXHIBITION & WELCOME COFFEE
9:00
-
9:05
Opening Remarks from Chairperson
9:05
-
9:35
Updates from the Therapeutic Goods Administration
  • The new expedited pathways for prescription medicines approval
  • The new orphan medicine eligibility criteria
  • TGA publication and transparency developments

Therapeutic Goods Administration Adrian Bootes Assistant Secretary, Prescription Medicines Authorisation Branch Therapeutic Goods Administration

9:35
-
10:15
Panel discussion: The medicine of the future is here now.

Which current advances in AI, Robotics, gene therapy, digital technologies, Virtual Reality and 3D Printing are entering our hospitals? A look at how they are going to shape the way we do business and interact with customers and patients.

MTP Connect Alfredo Martinez-Coll General Manager, Stakeholder Engagement MTP Connect

Murdoch Childrens Research Institute James Dromey PhD Chief Operating Officer Murdoch Childrens Research Institute

Further speakers to be revealed

10:15
-
10:45
Digital solutions for driving better health outcomes
  • How to forge relationships with consumers who are now the gatekeeper to their own healthcare
  • Case Study: Adjusting business processes to better align with patient/ practitioner behaviour and requirements
  • Methods to provide what patients and practitioners need through the latest in digital technology

Healthshare Chris Barakat Director of Business Development Healthshare

10:45
-
11:15
EXHIBITION & NETWORKING COFFEE BREAK
11:15
-
11:45
Orchestrating a Customer Centric Digital Engagement

More information coming soon…

IMS Health Amit Backliwal VP, T&S, China & SE Asia, TS SEA RG General Management IMS Health

11:45
-
12:15
Take an agile approach to digital pharma – without breaking the bank
  • The underlying features of a nimble marketing team & how to cultivate them
  • Creating a content, service and lead generation tool
  • Developing patient centric apps for additional access
  • How to encourage an agile approach in the senior leadership team

Aspen Pharma Richard Clement Group Digital Communication Manager Aspen Pharma

12:15
-
12:45
Create digital content that cuts through the noise
  • Create clear goals for your content strategy
  • The key traits of engaging and value-driven content
  • How to pick the right channels for the right audience
  • Beyond webinars – leveraging Facebook Live, Podcasts & video
  • The tools required to efficiently manage a cross team content strategy

Williams Lea Tag Trent Agnew Client Service Director Williams Lea Tag

12:45
-
13:45
EXHIBITION & NETWORKING LUNCH BREAK
13:45
-
14:15
Employee engagement: Balancing trust, motivation and measurement for a more productive workforce
  • Leverage the role of commercial excellence in supporting the sales and marketing functions
  • How can your firm attract and retain the best talent?
  • The key capabilities that we need to be developing to sustain future needs How to create a supportive and team focused culture

Mundipharma Damian Byers Director of Human Resources Mundipharma

14:15
-
14:45
Work customer relationships to drive commercial success over the long-term
  • What a customer-first model really means in terms of actions and responsibilities
  • See how you can differentiate your brand by improving the physician-patient relationship
  • How to drive cultural change internally to ensure staff realise future performance depends on a genuine approach to patients, carers and loved ones

CSL Behring Loretta Croker General Manager, Commercial Operations CSL Behring

14:45
-
15:25
Panel discussion Analysing the commercial team of the future.

With the growth of medical teams, non-existent blockbusters, the decrease in field force, development of niche products and restricted PBS funding, the question around relevance is one which we need to ask.

  • The business case for and against having a commercial team
  • How to respond to the changing needs of our customer and patients through a more flexible business structure
  • The growth of MSLs and their impact on marketing & sales teams
  • Analysing potential team scenarios in 5, 10 or 20 years time
  • Understand the factors which will impact on the structure of commercial teams

Takeda Pharmaceuticals Ben Hopkins Commercial Director Takeda Pharmaceuticals

Janssen Leisl Guest Head of HR ANZ Janssen

UCB Shaun Holmgreen Head - Operational Excellence UCB

MSD Josie Downey Director, Oncology Business Unit MSD

15:25
-
16:05
eyeforpharma key note panel discussion A future plan that works for both pharma and customers – is it possible?
  • To ensure the future performance of Australian pharma companies while customers are becoming more complex, how do we need to make more strategic collaboration and work together?
  • Where do we need to create change to build a long-term commercial business model?
  • How do leaders think our workforce will be different five years from now? How do you properly balance investments in new technology and new people/talent at the same time?

CSL Behring Loretta Croker General Manager, Commercial Operations CSL Behring

Further speakers to be confirmed

16:05
-
16:15
Closing Remarks from Chairperson
16:15
END OF CONFERENCE

DAY 1: Tuesday 10th October 2017

7:30
-
8:45
REGISTRATION, EXHIBITION & WELCOME COFFEE
8:45
-
8:50
Opening Remarks from Organiser
8:50
-
9:30
Opening Panel discussion The new normal: Discover how the smartest companies are achieving access within a cash strapped economy
  • The future of the PBS, impact of the May budget and financial considerations on the healthcare industry
  • Do we only have two choices: to make better use of the money we have or to find more money?
  • The alternative to having more PBS funding
  • How to shape the business model of tomorrow to sustain the new normal

MSD Luke Cornish Senior Government Relations Manager MSD

Department of Health Penny Shakespeare First Assistant Secretary, Pharmaceutical Benefits Division Department of Health

9:30
-
10:00
Access in the Asian pharma market and what it means to Australia
  • The key players in the Asian pharma market – China, Taiwan, Korea and Hong Kong
  • The reimbursement reality and how it varies by market
  • The differences between access models and what Australia can learn from them

Alexion Pharmaceuticals Simon McErlane Regional Medical Director Alexion Pharmaceuticals

10:00
-
10:30
EXHIBITION & NETWORKING COFFEE BREAK
10:30
-
11:00
Primary Care Reform: the implications and opportunities for your company
  • Understand the drivers of change and model of care being targeted with these reforms
  • How the market will encourage innovation to shift the epicentre of care to the patient
  • Examine the impact of data collection and outcomes measurement on the patient management
  • Greater opportunities for the generation of real world data

Sonic Clinical Services Dr Munro Neville Chief Medical Officer Sonic Clinical Services

11:00
-
11:30
Fireside chat with Medicines Australia

Opportunity for you to have a conversation with Medicines Australia around policy, the Code of Conduct, general priorities, how they work with government and to understand how you are influencing the policy environment.

Medicines Australia Milton Catelin CEO and Government & Public Affairs Executive Medicines Australia

Medicines Australia Elizabeth de Somer Director Policy Medicines Australia

Medicines Australia Deborah Monk Director Ethics and Compliance Medicines Australia

Workshop
11:30
-
12:30
Atlantis Healthcare @ Boyd: Patient programs that get results – driving and measuring outcomes
  • Patient programs – the missed opportunity
  • Shaping patient behaviour, and measuring success
  • Real-world Evidence (RWE) – the Celgene experience

Speaker Logo

McCann Health @ Lindsay: Truth about Doctors
  • The rapidly changing world and role of doctors
  • Three global tensions that are impacting doctors world wide
  • The role pharma can play in helping doctors adapt, navigate, and thrive in these times of significant change

Speaker Logo

12:30
-
13:15
EXHIBITION & NETWORKING LUNCH BREAK & WORKSHOPS
13:15-13:45
Put the patient first. Uncovering pharma's value through the patient experience
  • What do patients really want and need?
  • Understanding the patient ecosystem including carers and loved ones
  • The key elements of a patient support program
  • How can pharma tangibly improve the patient experience?

Novartis Glenn Montgomery Director, Patient Access and Healthcare Systems Novartis

Novartis Simon Fisher Chief Scientific Officer Novartis

13:45
-
14:25
Panel discussion Create patient centric solutions. The increasing importance of patient advocacy organisations and the patient voice.
  • The critical nature of patient centricity for delivering value in the Australian Healthcare sector
  • The role of patient organisations in the current patient ecosystem
  • The elements of an ideal pharma-patient organisation relationship
  • Understand the support gaps and how can pharma step in to provide an improved patient centric experience

Novartis Glenn Montgomery Director, Patient Access and Healthcare Systems Novartis

Biogen Kylie Bromley Associate Director of Sales & Marketing Biogen

Epilepsy Action Australia Carol Ireland CEO & Managing Director Epilepsy Action Australia

MS Australia Deidre MacKechnie CEO MS Australia

14:25
-
14:55
Design & deploy a disease awareness campaign
  • The benefits of disease awareness campaigns and their roles in creating patient centric opportunities
  • The basic elements of an awareness campaign
  • Understand the negative effects of social stigma and the role of pharma in turning this around
  • Leveraging traditional media as well as digital channels
  • Working with key partners such as HCOs and/or media agencies

Galderma Jessica Danaher Brand Manager – ACNE and Rosacea Galderma

14:55
-
15:25
How to become the go-to source for healthcare content and increase engagement
  • The importance of credible content and reliable content sources for consumers and physicians
  • Why scientific data is the gateway to good engagement – and how you can use digital techniques to enhance communications
  • The benefits of enhanced content: how to measure ROI and plan for your success

Wiley Julia Ballard Senior Journal Publishing Manager Wiley

15:25
-
15:55
EXHIBITION & NETWORKING COFFEE BREAK
15:55
-
16:25
Inform your healthcare communications plan with updates on the latest trends and 2017 Pharma Marketing Automation Barometer results
  • Inspirational health & consumer marketing cases studies from around the globe.
  • Moving beyond traditional campaigns: machine learning, content, context and social techniques.
  • Highlights from a marketing technology readiness report on 14 of Australia’s largest pharma companies.
  • Current trends in the utilisation of marketing automation channels and functions.
  • Benchmarking HCP opt-in ratios: Are there any clear leaders in the pack?

Orchard

Speaker from Orchard to be confirmed

16:25
-
17:05
Panel discussion How to respond more effectively to our changing customers’ needs.
  • Understanding the pressures which are changing our customers’ behaviour
  • Recognise the pharma value-add and how to deliver it
  • Identify more innovative (and effective) means of communication
  • Altering our day to day activities need to better service our audience

iNova Pharma Roberto Castro Commercial Operations Manager iNova Pharma

AbbVie Alida Rossi Customer Excellence Director AbbVie


Further speakers to be revealed

17:05
-
19:00
EXHIBITION & NETWORKING DRINKS RECEPTION

Register Now

There are only a limited number of passes left - Secure your place to this sell out event!

DAY 2: Wednesday 11 October 2017

8:30
-
9:00
REGISTRATION, EXHIBITION & WELCOME COFFEE
9:00
-
9:05
Opening Remarks from Chairperson
9:05
-
9:35
Updates from the Therapeutic Goods Administration
  • The new expedited pathways for prescription medicines approval
  • The new orphan medicine eligibility criteria
  • TGA publication and transparency developments

Therapeutic Goods Administration Adrian Bootes Assistant Secretary, Prescription Medicines Authorisation Branch Therapeutic Goods Administration

9:35
-
10:15
Panel discussion: The medicine of the future is here now.

Which current advances in AI, Robotics, gene therapy, digital technologies, Virtual Reality and 3D Printing are entering our hospitals? A look at how they are going to shape the way we do business and interact with customers and patients.

MTP Connect Alfredo Martinez-Coll General Manager, Stakeholder Engagement MTP Connect

Murdoch Childrens Research Institute James Dromey PhD Chief Operating Officer Murdoch Childrens Research Institute

Further speakers to be revealed

10:15
-
10:45
Digital solutions for driving better health outcomes
  • How to forge relationships with consumers who are now the gatekeeper to their own healthcare
  • Case Study: Adjusting business processes to better align with patient/ practitioner behaviour and requirements
  • Methods to provide what patients and practitioners need through the latest in digital technology

Healthshare Chris Barakat Director of Business Development Healthshare

10:45
-
11:15
EXHIBITION & NETWORKING COFFEE BREAK
11:15
-
11:45
Orchestrating a Customer Centric Digital Engagement

More information coming soon…

IMS Health Amit Backliwal VP, T&S, China & SE Asia, TS SEA RG General Management IMS Health

11:45
-
12:15
Take an agile approach to digital pharma – without breaking the bank
  • The underlying features of a nimble marketing team & how to cultivate them
  • Creating a content, service and lead generation tool
  • Developing patient centric apps for additional access
  • How to encourage an agile approach in the senior leadership team

Aspen Pharma Richard Clement Group Digital Communication Manager Aspen Pharma

12:15
-
12:45
Create digital content that cuts through the noise
  • Create clear goals for your content strategy
  • The key traits of engaging and value-driven content
  • How to pick the right channels for the right audience
  • Beyond webinars – leveraging Facebook Live, Podcasts & video
  • The tools required to efficiently manage a cross team content strategy

Williams Lea Tag Trent Agnew Client Service Director Williams Lea Tag

12:45
-
13:45
EXHIBITION & NETWORKING LUNCH BREAK
13:45
-
14:15
Employee engagement: Balancing trust, motivation and measurement for a more productive workforce
  • Leverage the role of commercial excellence in supporting the sales and marketing functions
  • How can your firm attract and retain the best talent?
  • The key capabilities that we need to be developing to sustain future needs How to create a supportive and team focused culture

Mundipharma Damian Byers Director of Human Resources Mundipharma

14:15
-
14:45
Work customer relationships to drive commercial success over the long-term
  • What a customer-first model really means in terms of actions and responsibilities
  • See how you can differentiate your brand by improving the physician-patient relationship
  • How to drive cultural change internally to ensure staff realise future performance depends on a genuine approach to patients, carers and loved ones

CSL Behring Loretta Croker General Manager, Commercial Operations CSL Behring

14:45
-
15:25
Panel discussion Analysing the commercial team of the future.

With the growth of medical teams, non-existent blockbusters, the decrease in field force, development of niche products and restricted PBS funding, the question around relevance is one which we need to ask.

  • The business case for and against having a commercial team
  • How to respond to the changing needs of our customer and patients through a more flexible business structure
  • The growth of MSLs and their impact on marketing & sales teams
  • Analysing potential team scenarios in 5, 10 or 20 years time
  • Understand the factors which will impact on the structure of commercial teams

Takeda Pharmaceuticals Ben Hopkins Commercial Director Takeda Pharmaceuticals

Janssen Leisl Guest Head of HR ANZ Janssen

UCB Shaun Holmgreen Head - Operational Excellence UCB

MSD Josie Downey Director, Oncology Business Unit MSD

15:25
-
16:05
eyeforpharma key note panel discussion A future plan that works for both pharma and customers – is it possible?
  • To ensure the future performance of Australian pharma companies while customers are becoming more complex, how do we need to make more strategic collaboration and work together?
  • Where do we need to create change to build a long-term commercial business model?
  • How do leaders think our workforce will be different five years from now? How do you properly balance investments in new technology and new people/talent at the same time?

CSL Behring Loretta Croker General Manager, Commercial Operations CSL Behring

Further speakers to be confirmed

16:05
-
16:15
Closing Remarks from Chairperson
16:15
END OF CONFERENCE

Don't miss out - register now

There are only a limited number of passes left - Secure your place to this sell out event!